Early detection of heightened NE tone could serve as a biomarker and a treatment target, with sympatholytic or β-blocker strategies potentially improving insulin dynamics in prediabetes and new-onset T2D [86,87,88]. This evidence concerns the gene INS and prediabetes syndrome.